Loading

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Clinical trial

NCT06039384

1 development in the corpus

NCT06039384

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials1 Reviews Guidelines

Latest

Everything in the corpus, newest first.

SEP 8, 2026 · PHASE 1 TRIAL

A Study of INCB099280 in Combination With Adagrasib in Adults With Advanced Solid Tumors Harboring a KRASG12C Mutation

ClinicalTrials.gov

Phase 1 dose-escalation study of a novel combination in advanced solid tumors, terminated after enrolling only 6 participants; no results are posted in this registry record.

PreliminaryNCT06039384 Adagrasib Advanced Solid Tumors

Reported

Planned enrollment6

Recruitment statusTERMINATED

PhasePHASE 1

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support